4.3. Nanotechnology Based Methods
This protocol is extracted from research article:
Nucleic Acid Testing of SARS-CoV-2
Int J Mol Sci, Jun 7, 2021; DOI: 10.3390/ijms22116150

Nanotechnology has already proven its value through its diagnostic, vaccine, and therapeutic applications that have expanded into clinical applications [195]. Scientists have shown that nucleic acid detection using nanomaterials for viral infectious diseases now have various advantages in the diagnostic field [196]. Moreover, nanomaterials are powerful tools for the diagnosis, prevention, and treatment of COVID-19 [197].

Magnetic nanoparticles have been used in RT-qPCR diagnosis for the extraction of viral RNA from SARS-CoV-2. This method merges the lysis and binding steps, and the poly (amino ester) with carboxyl groups (PC)-coated magnetic nanoparticles (pcMNPs)-RNA complexes can be directly introduced into RT-qPCR reactions [198]. In addition, a test has been developed to diagnose SARS-CoV-2 that can rapidly detect the virus. The test is performed using gold nanoparticles to detect specific proteins such as nucleocapsid phosphoprotein. In the presence of gold nanoparticles, the test is positive upon the color of the liquid reagent changing from purple to blue [199]. Nanoparticles that can be applied in the RT-qPCR diagnosis are shown in Figure 1E.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.